Beyond analysts' top-and-bottom-line estimates for PTC Inc. (PTC), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
The U.S. Food and Drug Administration has approved PTC Therapeutics' oral drug to treat a rare inherited metabolic disorder that prevents the body from properly breaking down certain amino acids, the company said on Monday.
PTC expects Q3 revenues of up to $600M and EPS as high as $1.30, driven by AI-powered PLM and CAD momentum.
Does PTC Inc. (PTC) have what it takes to be a top stock pick for momentum investors? Let's find out.
PTC Inc. (PTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
PTC Inc. (PTC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Shares of software company PTC ended Wednesday's session up 18%.
PTC debuts Arena SCI to tackle supply chain risk with AI, even as mounting debt highlights growing financial pressure.
PTC debuts the first cloud-native MBD in Onshape, aiming to cut 2D drawing reliance and streamline product development.
PTC's diversified software suite and high-margin recurring revenue model drive solid fundamentals, despite capability competition from Autodesk and Dassault. Operating margins are expanding, now at ~35%, and PTC trades at a valuation discount versus peers, offering attractive upside if ARR growth reaccelerates. Strategic SaaS pivots and targeted R&D deliver superior margin efficiency and innovation, positioning PTC well for long-term cloud-native trends in industrials.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.